GI Dynamics
134 articles about GI Dynamics
-
GI Dynamics Release: EndoBarrier Makes Advancement Toward German Reimbursement
11/23/2016
-
GI Dynamics Release: German Registry Releases Positive EndoBarrier Data At EASD
11/9/2016
-
GI Dynamics: Appendix 4C: Quarter Ended 30 June 2016
7/29/2016
-
GI Dynamics Announces Final Efficacy And Safety Results Of U.S. ENDO Trial
6/23/2016
-
GI Dynamics Announces Results Of Endobarrier Therapy Studies At Digestive Disease Week Meeting
6/13/2016
-
GI Dynamics Announces Endobarrier® Therapy Data To Be Presented At American Diabetes Association Annual Meeting
6/9/2016
-
New GI Dynamics CEO Schorer Looks To Reboot EndoBarrier
5/25/2016
-
GI Dynamics Appoints Chief Compliance Officer
5/10/2016
-
GI Dynamics Releases Safety And Efficacy Data For Endobarrier Therapy
5/9/2016
-
GI Dynamics Appoints Chief Financial Officer
5/6/2016
-
GI Dynamics Appoints Medtech Vet Scott Schorer as President & CEO
3/23/2016
-
German Diabetes Society Releases Statement Regarding GI Dynamics’ Termination of U.S. ENDO Trial
9/28/2015
-
GI Dynamics Axes Workforce by 46%
8/21/2015
-
GI Dynamics: Appendix 4C Quarterly Report Quarter Ended 30 June 2015
7/30/2015
-
GI Dynamics Discontinues U.S. Trial of EndoBarrier Therapy
7/30/2015
-
GI Dynamics Release: New Data Presented At American Diabetes Association Demonstrate Early Effect Of Endobarrier Therapy On Glucose Control And Bile Acid Regulators
6/8/2015
-
GI Dynamics: Appendix 4C Quarterly Report Quarter Ended 31 March 2015
4/30/2015
-
GI Dynamics Stock Freefalls After FDA Halts Trial
3/9/2015
-
GI Dynamics To Axe 10% Of Workforce
12/10/2014
-
GI Dynamics Resumes Shipments Of EndoBarrier® Product
12/1/2014